Login / Signup

A Comparison of Bone Marrow Morphology and Peripheral Blood Findings in Low and High Level JAK2 V617F Allele Burden.

Emina BabarovićBlažen MarijićLuka VranićJosipa BanToni ValkovićIta Hadžisejdić
Published in: Diagnostics (Basel, Switzerland) (2023)
Cases with low level JAK2 V617F mutations are increasingly detected; however, the clinical interpretation of the low allele JAK2 burden may be challenging. The aim of this study is to analyze and compare the bone marrow morphology and peripheral blood findings in the low level JAK2 V617F allele burden (≤15% of JAK2 ) and high JAK2 V617F mutation burden patients (>15% JAK2 ). In total, 122 JAK2 V617F positive cases with concomitant bone marrow biopsies and peripheral blood findings were re-evaluated (62 low and 60 high level JAK2 V617F positive). Within the low burden group, normal looking megakaryocytes ( p = 0.0005) were more frequently found, compared with those with no atypia ( p = 0.0003), their number was more frequently not increased ( p = 0.009), and they did not form clusters ( p = 0.001). We found statistically significant difference in the number of platelet ( p = 0.0003) and hematocrit levels ( p = 0.032) when comparing the JAK2 V617F <3% and ≥3% mutation burden. In the high-level burden, the megakaryocytes were more frequently atypical ( p = 0.054), and more frequently formed clusters ( p = 0.053) with nuclei with maturation defects ( p ≤ 0.0001). In conclusion, the JAK2 V617F mutation burden is reflected by morphological changes in the bone marrow and careful follow up of each and every patient with a low JAK2 V617F positivity is mandatory.
Keyphrases
  • bone marrow
  • peripheral blood
  • mesenchymal stem cells
  • risk factors
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors